{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:15:57Z","timestamp":1773008157070,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Egyptian Russian University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Green analytical chemistry is an innovative approach to making analytical experiments more environmentally friendly, safer for humans, and less toxic to the environment by utilizing eco-friendly reagents and chemicals. Diabetics are twice as likely to experience hypertension compared to nondiabetics. Individuals with both conditions face a significantly increased risk of early microvascular and macrovascular complications. Regular monitoring helps ensure the drug concentration remains within the therapeutic range, maximizing its effectiveness. Herein, a high-performance liquid chromatographic (HPLC) method is provided to evaluate and isolate the studied drugs in the presence of their toxic impurities. The study involves the simultaneous administration of two crucial drugs: the antidiabetic metformin and the antihypertensive bisoprolol. We have investigated their pure form in spiked human plasma, as well as their interaction while their possible toxic impurities are present as melamine and cyanoguanidine. The optimal conditions were achieved using a mobile phase consisting of 0.1 M SDS, 0.1% ortho-phosphoric acid in water, and 10% isopropanol at a flow rate of 1.0\u00a0mL\/min. The pH was adjusted to 5.0 using triethylamine, and the column temperature was maintained at 25\u00a0\u00b0C on a symmetry C18 column (Kinetex 1.7\u00b5 C18 100A, 2.1-mm\u2009\u00d7\u200950-mm), with detection at 230 nm. Following the International Conference of Harmonization guideline, the method was successfully validated within the linearity range of 1\u201325\u00a0\u00b5g\/mL for metformin and bisoprolol. Notably, the LOQ was determined to be 0.92\u00a0\u00b5g\/mL for metformin and 0.54\u00a0\u00b5g\/mL for bisoprolol. The established method epitomizes accuracy, cost-effectiveness, selectivity, and reproducibility. The evaluation of the suggested approaches\u2019 level of greenness was meticulously conducted using a variety of assessments, including the Analytical eco-scale system, the Modified Green Analytical Procedure Index (MoGAPI), The Analytical Green Star Area (AGSA), Blueness evaluation using BAGI tools, Carbon footprint (CaFRI), Click Analytical Chemistry Index (CACI) and White analytical chemistry (WAC).<\/jats:p>","DOI":"10.1038\/s41598-025-22712-w","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:39:37Z","timestamp":1761817177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eco-friendly micellar HPLC for metformin and bisoprolol analysis in diverse matrices with a green and blueness perspective on drug purity and safety"],"prefix":"10.1038","volume":"15","author":[{"given":"Naglaa Abdel Sattar","family":"Kabil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda Mohamed","family":"El-Henawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Abd Elnasser","family":"Labib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Darweish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"22712_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/acs.chemrev.7b00571","volume":"118","author":"CJ Clarke","year":"2018","unstructured":"Clarke, C. J., Tu, W. C., Levers, O., Br\u00f6hl, A. & Hallett, J. P. Green and sustainable solvents in chemical processes. Chem. Rev. 118, 747\u2013800 (2018).","journal-title":"Chem. Rev."},{"key":"22712_CR2","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1038\/sj.jhh.1000983","volume":"14","author":"F Contreras","year":"2000","unstructured":"Contreras, F., Rivera, M., Vasquez, J., de la Parte, M. A. & Velasco, M. Diabetes and hypertension physiopathology and therapeutics. J. Hum. Hypertens. 14, S26\u2013S31 (2000).","journal-title":"J. Hum. Hypertens."},{"key":"22712_CR3","first-page":"S179","volume":"47","author":"C Disease","year":"2023","unstructured":"Disease, C. & Management, R. Standards of care in diabetes\u20142024. Diabetes Care 47, S179\u2013S218 (2023).","journal-title":"Diabetes Care"},{"key":"22712_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2020-039940","volume":"10","author":"KB Schesing","year":"2020","unstructured":"Schesing, K. B. et al. Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: A qualitative study. BMJ Open 10, 1\u201314 (2020).","journal-title":"BMJ Open"},{"key":"22712_CR5","unstructured":"Sweetman, S. Martidale: The Complete Drug Reference. Thirty eight (London 2014)."},{"key":"22712_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jfda.2018.06.007","volume":"27","author":"A Gedawy","year":"2019","unstructured":"Gedawy, A., Al-Salami, H. & Dass, C. R. Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide. J. Food Drug Anal. 27, 315\u2013322 (2019).","journal-title":"J. Food Drug Anal."},{"key":"22712_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/bmc.195","volume":"16","author":"AJ Braza","year":"2002","unstructured":"Braza, A. J., Modamio, P., Lastra, C. F. & Mari\u00f1o, E. L. Development, validation and analytical error function of two chromatographic methods with fluorimetric detection for the determination of bisoprolol and metoprolol in human plasma. Biomed. Chromatogr. 16, 517\u2013522 (2002).","journal-title":"Biomed. Chromatogr."},{"key":"22712_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham, G. G. et al. Clinical pharmacokinetics of metformin. Clin. Pharmacokinet. 50, 81\u201398 (2011).","journal-title":"Clin. Pharmacokinet."},{"key":"22712_CR9","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1177\/039139889902201204","volume":"22","author":"K Kanegae","year":"1999","unstructured":"Kanegae, K. et al. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension. Int. J. Artif. Organs 22, 798\u2013804 (1999).","journal-title":"Int. J. Artif. Organs"},{"key":"22712_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/HYPERTENSIONAHA.120.13896","volume":"75","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty, S. et al. Metabolites and hypertension: Insights into hypertension as a metabolic disorder: 2019 Harriet Dustan Award. Hypertension 75, 1386\u20131396 (2020).","journal-title":"Hypertension"},{"key":"22712_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00228-020-02937-6","volume":"76","author":"S Mom\u010dilovi\u0107","year":"2020","unstructured":"Mom\u010dilovi\u0107, S. et al. Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension. Eur. J. Clin. Pharmacol. 76, 1539\u20131546 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"22712_CR12","unstructured":"The British Pharmacopoeia (Her Majesty\u2019s Stationary Office, London 2013)."},{"key":"22712_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/10590501.2013.844758","volume":"31","author":"CY Chu","year":"2013","unstructured":"Chu, C. Y. & Wang, C. C. Toxicity of melamine: the public health concern. J. Environ. Sci. Heal. Part C 31, 342\u2013386 (2013).","journal-title":"J. Environ. Sci. Heal. Part C"},{"key":"22712_CR14","first-page":"61","volume":"109","author":"Y Matsushima","year":"1991","unstructured":"Matsushima, Y. et al. Subchronic oral toxicity study of cyanoguanidine in F344 rats. Eisei Shikenjo Hokoku 109, 61\u201366 (1991).","journal-title":"Eisei Shikenjo Hokoku"},{"key":"22712_CR15","first-page":"626","volume":"21","author":"JD Orr","year":"2003","unstructured":"Orr, J. D., Krull, I. S. & Swartz, M. E. Validation of impurity methods, part I. LC-GC North Am. 21, 626\u2013633 (2003).","journal-title":"LC-GC North Am."},{"key":"22712_CR16","unstructured":"ICH Harmonised tripartite guidelineQ3A (R2): Impurities in new drug substance of analytical procedures: Text and methodology. In: International Conference on Harmonization, Geneva (2005)."},{"key":"22712_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.9734\/BJMMR\/2015\/11655","volume":"5","author":"M Rokonujjaman","year":"2015","unstructured":"Rokonujjaman, M., Salam, M. & Sultan, M. In vitro study of interactions of sildenafil citrate with bovine serum albumin in presence of bisoprolol fumarate and metformin hydrochloride by fluorescence spectrophotometry. Br. J. Med. Med. Res. 5, 362\u2013375 (2015).","journal-title":"Br. J. Med. Med. Res."},{"key":"22712_CR18","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00216-010-4101-1","volume":"398","author":"ALN Van Nuijs","year":"2010","unstructured":"Van Nuijs, A. L. N. et al. Optimization and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater. Anal. Bioanal. Chem. 398, 2211\u20132222 (2010).","journal-title":"Anal. Bioanal. Chem."},{"key":"22712_CR19","first-page":"593","volume":"67","author":"G K\u0142aczkow","year":"2010","unstructured":"K\u0142aczkow, G. & Anuszewska, E. L. Determination of impurities in medical products containing metformin hydrochloride. Acta Pol. Pharm. - Drug Res. 67, 593\u2013598 (2010).","journal-title":"Acta Pol. Pharm. - Drug Res."},{"key":"22712_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jssc.202000937","volume":"44","author":"MA Magdy","year":"2021","unstructured":"Magdy, M. A., Ali, N. W., Taha, A. A., Elgebaly, A. M. & Farid, N. F. Different chromatographic methods for determination of alogliptin benzoate, metformin hydrochloride, and metformin impurity in bulk and pharmaceutical dosage form. J. Sep. Sci. 44, 833\u2013842 (2021).","journal-title":"J. Sep. Sci."},{"key":"22712_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107856","volume":"182","author":"MG Fawzy","year":"2022","unstructured":"Fawzy, M. G., Hafez, H. M., Hassan, W. E., Mostafa, A. A. & Sayed, R. A. Application of molecular docking approach in a novel eco-friendly impurity profiling HPLC-UV method for the simultaneous estimation of ternary hypoglycemic pharmaceutical mixture. Microchem. J. 182, 107856 (2022).","journal-title":"Microchem. J."},{"key":"22712_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1365\/s10337-008-0542-5","volume":"67","author":"MS Ali","year":"2008","unstructured":"Ali, M. S., Rafiuddin, S., Ghori, M. & Khatri, A. R. Simultaneous determination of metformin hydrochloride, cyanoguanidine and melamine in tablets by mixed-mode HILIC. Chromatographia 67, 517\u2013525 (2008).","journal-title":"Chromatographia"},{"key":"22712_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jaoacint\/qsab171","volume":"105","author":"FF Abdallah","year":"2022","unstructured":"Abdallah, F. F., Magdy, F., Abdelaleem, E. A. & Emam, A. A. Spectrophotometric determination of metformin in different pharmaceutical combinations with glipizide or sitagliptin in presence of toxic impurities of metformin. J. AOAC Int. 105, 657\u2013664 (2022).","journal-title":"J. AOAC Int."},{"key":"22712_CR24","doi-asserted-by":"crossref","unstructured":"Snyder, L. R., Kirkland, J. J. & Dolan, J. W. Introduction to Modern Liquid Chromatography Introduction to Modern Liquid Chromatography Second Edition (2009).","DOI":"10.1002\/9780470508183"},{"key":"22712_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.30574\/ijsra.2025.15.1.0929","volume":"15","author":"AW Ansari","year":"2025","unstructured":"Ansari, A. W. et al. High-performance liquid chromatography (HPLC): Innovations in analytical techniques and applications. Int. J. Sci. Res. Arch. 15, 155\u2013166 (2025).","journal-title":"Int. J. Sci. Res. Arch."},{"key":"22712_CR26","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.jsps.2024.102206","volume":"32","author":"S Alhabardi","year":"2024","unstructured":"Alhabardi, S., Mahrous, G., Alshahrani, A. & Taha, E. Pharmaceutical quality of dispersible diclofenac tablets in the Saudi market. Saudi Pharm. J. 32, 102206 (2024).","journal-title":"Saudi Pharm. J."},{"key":"22712_CR27","unstructured":"ICH Harmonised Tripartite GuidelineQ2 (R1): Validation of analytical procedures: text and methodology. In: International Conference on Harmonization, Geneva (2005)."},{"key":"22712_CR28","first-page":"231","volume":"19","author":"MS Arayne","year":"2006","unstructured":"Arayne, M. S., Sultana, N. & Zuberi, M. H. Development and validation of RP-HPLC method for the analysis of metformin. Pak. J. Pharm. Sci. 19, 231\u2013235 (2006).","journal-title":"Pak. J. Pharm. Sci."},{"key":"22712_CR29","first-page":"720","volume":"120","author":"AD Panainte","year":"2016","unstructured":"Panainte, A. D., Vieriu, M., \u0162antaru, G., Apostu, M. & Bibire, N. Fast RP-HPLC method for the determination of bisoprolol. Rev. Med. Chir. Soc. Med. Nat. Iasi 120, 720\u2013726 (2016).","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"key":"22712_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka, A., Migaszewski, Z. M., Konieczka, P. & Namie\u015bnik, J. Analytical eco-scale for assessing the greenness of analytical procedures. TrAC Trends Anal. Chem. 37, 61\u201372 (2012).","journal-title":"TrAC Trends Anal. Chem."},{"key":"22712_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/analytica5030030","volume":"5","author":"FR Mansour","year":"2024","unstructured":"Mansour, F. R., P\u0142otka-Wasylka, J. & Locatelli, M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: Case studies and applications. Analytica 5, 451\u2013457 (2024).","journal-title":"Analytica"},{"key":"22712_CR32","doi-asserted-by":"publisher","first-page":"102051","DOI":"10.1016\/j.scp.2025.102051","volume":"46","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R., Bedair, A., Belal, F., Magdy, G. & Locatelli, M. Analytical green star area (AGSA) as a new tool to assess greenness of analytical methods. Sustain. Chem. Pharm. 46, 102051 (2025).","journal-title":"Sustain. Chem. Pharm."},{"key":"22712_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10661-010-1678-y","volume":"178","author":"D Pandey","year":"2011","unstructured":"Pandey, D., Agrawal, M. & Pandey, J. S. Carbon footprint: Current methods of estimation. Environ. Monit. Assess. 178, 135\u2013160 (2011).","journal-title":"Environ. Monit. Assess."},{"key":"22712_CR34","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality. Green Chem. 25, 7598\u20137604 (2023).","journal-title":"Green Chem."},{"key":"22712_CR35","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.sampre.2025.100164","volume":"14","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R., Bedair, A. & Locatelli, M. Click analytical chemistry index as a novel concept and framework, supported with open source software to assess analytical methods. Adv. Sample Prep. 14, 100164 (2025).","journal-title":"Adv. Sample Prep."},{"key":"22712_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s43094-023-00546-5","volume":"9","author":"P Prajapati","year":"2023","unstructured":"Prajapati, P., Rana, B., Pulusu, V. S. & Shah, S. Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: Incorporating hybrid principles of white analytical chemistry and design of experiments. Futur. J. Pharm. Sci. 9, 93 (2023).","journal-title":"Futur. J. Pharm. Sci."},{"key":"22712_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s42250-023-00819-9","volume":"7","author":"P Prajapati","year":"2024","unstructured":"Prajapati, P., Salunkhe, M., Pulusu, V. S. & Shah, S. Integrated approach of white analytical chemistry and analytical quality by design to multipurpose RP-HPLC method for synchronous estimation of multiple fixed-dose combinations of paracetamol. Chem. Afr. 7, 1353\u20131371 (2024).","journal-title":"Chem. Afr."},{"key":"22712_CR38","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s42250-023-00835-9","volume":"7","author":"P Prajapati","year":"2024","unstructured":"Prajapati, P., Rana, B., Pulusu, V. S. & Mishra, A. Multipurpose RP-HPLC method for simultaneous estimation of fixed-dose combinations of anti-diabetic drugs: integrating green, economical, and robust approaches with design of experiments and white analytical chemistry. Chem. Afr. 7, 1385\u20131400 (2024).","journal-title":"Chem. Afr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22712-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22712-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:39:39Z","timestamp":1761817179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22712-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22712"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22712-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee at the Faculty of Pharmacy, Egyptian Russian University (1\/5\/2024\/No.ECH-025). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"I affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"37930"}}